Massive Bio, ONCOassist Launch Strategic Partnership

News
Article

Collaboration to focus on enhancing physician engagement in clinical trials and cancer research.

Life science data, medicine data dashboard, biology innovation, biotechnology data science, clinical trials, DNA analitics. Image Credit: Adobe Stock Images/Store4FUN

Image Credit: Adobe Stock Images/Store4FUN

Massive Bio and ONCOassist have announced in a joint press release that they have entered into a strategic partnership with the aim of optimizing patient-centric care and enhancing physician engagement in clinical trials and cancer research. As a result of the joint venture, the organizations are hoping to reshape the oncology landscape.

"In the rapidly evolving realm of oncology, our partnership with ONCOassist stands as a testament to our dedication to pushing the boundaries and ensuring every cancer patient receives optimal care,” said Arturo Loaiza-Bonilla, MD, co-founder, chief medical officer, Massive Bio, in the aforementioned press release.

Reference: Massive Bio and ONCOassist® Announce Strategic Partnership at ESMO 2023. BusinessWire. October 19, 2023. Accessed October 25, 2023. https://www.businesswire.com/news/home/20231019250308/en/Massive-Bio-and-ONCOassist%C2%AE-Announce-Strategic-Partnership-at-ESMO-2023

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.